April 2026 FDA Recall Omega-3-acid Ethyl Esters by The Harvard Drug Group Llc
D-0493-2026 - Failed Capsule Specifications

This Class II drug recall was voluntarily initiated by The Harvard Drug Group Llc on April 9, 2026 for the product Omega-3-acid Ethyl Esters. The FDA reported the reason for recall as failed capsule specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0493-2026

Reason for Recall
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Initiated
04-09-2026
Reported
04-29-2026
Quantity
2,238 5 x 10 unit dose cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC
Nationwide in the USA
Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06

Batch or Lot Expiration Information

Lot# : Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026

Affected Packages Involved in this Recall